NCT06791187View on ClinicalTrials.gov

A Study in Healthy People to Test Whether BI 1291583 Influences the Amount of Dabigatran in the Body

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 23, 2025

Primary Completion Date

February 21, 2025

Study Completion Date

March 27, 2025

Conditions
Healthy
Interventions
DRUG

dabigatran etexilate

dabigatran etexilate

DRUG

BI 1291583

BI 1291583

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT06791187 - A Study in Healthy People to Test Whether BI 1291583 Influences the Amount of Dabigatran in the Body | Biotech Hunter | Biotech Hunter